%0 Journal Article %A Seyed Hamidreza Bagheri %A Alimohamad Asghari %A Mohammad Farhadi %A Ahmad Reza Shamshiri %A Ali Kabir %A Seyed Kamran Kamrava %A Maryam Jalessi %A Alireza Mohebbi %A Rafieh Alizadeh %A Ali Asghar Honarmand %A Babak Ghalehbaghi %A Alireza Salimi %T Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak %D 2020 %R 10.1101/2020.03.23.20041889 %J medRxiv %P 2020.03.23.20041889 %X Background Recent surge of olfactory dysfunction in patients who were referred to ENT clinics and concurrent COVID-19epidemic in Iran motivated us to evaluate anosmic/hyposmic patients to find any relation between these two events.Methods This is a cross-sectional study with an online checklist on voluntary cases in all provinces of Iran between the 12th and 17th March, 2020. Cases was defined as self-reported anosmia/hyposmia in responders fewer than 4 weeks later (from start the of COVID-19 epidemic in Iran). Variables consist of clinical presentations, related past medical history, family history of recent respiratory tract infection and hospitalization.Results In this study 10069 participants aged 32.5±8.6 (7-78) years, 71.13% female and 81.68% non-smoker completed online checklist. They reported 10.55% a history of a trip out of home town and 1.1% hospitalization due to respiratory problems recently. From family members 12.17% had a history of severe respiratory disease in recent days and 48.23% had anosmia/hyposmia.Correlation between the number of olfactory disorder and reported COVID-19 patients in all 31 provinces till 16th March 2020 was highly significant (Spearman correlation coefficient=0.87, p-Value<0.001). The onset of anosmia was sudden in 76.24% and till the time of filling the questionnaire in 60.90% of patients decreased sense of smell was constant. Also 83.38 of this patients had decreased taste sensation in association with anosmia.Conclusions It seems that we have a surge in outbreak of olfactory dysfunction happened in Iran during the COVID-19 epidemic. The exact mechanism of anosmia/hyposmia in COVID-19 patients’ needs further investigations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received and this study is performed by Ear, Nose, Throat and Head and Neck Surgery Research Center (Iran University of Medical Sciences) in cooperation with Iran Medical Council.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe online questionnaire developed by Ear, Nose, Throat and Head and Neck Surgery Research Center (Iran University of Medical Sciences) in cooperation with Iran Medical Council. The software incorporated into the website of Iran Medical Council for corona epidemics (www.corona.ir). The online questionnaire was in google document format (go.irimc.org/smelltest). %U https://www.medrxiv.org/content/medrxiv/early/2020/03/27/2020.03.23.20041889.full.pdf